Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Improving memory and learning in Portuguese patients with Multiple Sclerosis

Official title: Testing the Efficacy of a Memory Training Program to Improve New Learning and Memory in Portuguese Patients With Multiple Sclerosis: A Randomized Clinical Trial

Run by Centro Hospitalar De São João, E.P.E. · NCT06723444 · Data updated 2026-11-12

This study is testing a new memory training program to see if it can help people in Portugal with Multiple Sclerosis improve their memory and learning skills.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment80 (estimated)
SponsorCentro Hospitalar De São João, E.P.E.
Academic / other
Locations1 site (Porto)
StatusRecruiting
StartedDecember 5, 2024
Main results expectedDecember 2026
Study endsAugust 2028
Registry record updatedFebruary 12, 2025
Trial IDNCT06723444 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult native Portuguese speakers with a confirmed diagnosis of MS and documented impairments in new learning abilities.

Probably not a fit

Patients with recent exacerbations, significant neurological histories, or those on certain medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to address memory and learning deficits commonly experienced by patients with Multiple Sclerosis (MS) in Portugal. It will implement the Modified Story Memory Technique (mSMT), a cognitive rehabilitation program designed to enhance memory through structured sessions that incorporate visual imagery and contextual learning. Participants will be randomly assigned to either a memory retraining group or a placebo control group, with assessments conducted at baseline, immediately after the intervention, and during long-term follow-ups to evaluate cognitive function and daily life impacts. The study seeks to fill a gap in existing research by testing the efficacy of mSMT specifically in the Portuguese MS population.

Why it matters

Potential benefit: If successful, this intervention could significantly improve cognitive function and quality of life for patients with Multiple Sclerosis.

How similar studies have gone: Previous studies have shown the effectiveness of similar cognitive rehabilitation techniques in various populations, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* established diagnosis of MS, according to McDonald criteria;
* adult native Portuguese speakers;
* at least four years of education;
* free of exacerbations and use of steroids for at least one month, and no neurologic history other than MS;
* no history of major depressive disorder, schizophrenia, bipolar disorder, and no history of substance use/dependence;
* no significant visual impairment that impacts the ability to see testing materials and language comprehension as measured by the Token Test;
* impaired verbal new learning as documented by a performance of -1.0 or worse standard deviations below the mean, using age, sex and education-adjusted Portuguese norms on the Selective Reminding Test from the Brief Repeatable Battery of Neuropsychological Tests.

Exclusion Criteria:

* an exacerbation within one month;
* neurological history of head injury, stroke, seizures, or any other significant neurological history;
* patients on steroids, benzodiazepines, and/or neuroleptics;
* patients with an active diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder;
* poor visual acuity, diplopia, or nystagmus;
* inability to understand directions and following one, two, and three step commands;
* and intact new learning and memory.

Where it's running

  • Centro Hospitalar Universitário de São João
    Porto, Portugal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.